Pancreatic Resection for Side-Branch Intraductal Papillary Mucinous Neoplasm (SB-IPMN): a Contemporary Single-Institution Experience
- 420 Downloads
Given the malignant potential of main duct intraductal papillary mucinous neoplasm (M-IPMN), surgical resection is generally indicated. With regard to side-branch intraductal papillary mucinous neoplasm (SB-IPMN), resection vs. observation is a topic of debate. Further review of SB-IPMN is necessary to clarify appropriate management. The primary focus of this project is to determine the incidence of malignant final pathology for patients undergoing surgery for isolated SB-IPMN with non-malignant fine-needle aspiration (FNA) cytology. We also sought to describe the relationship between factors considered in the international consensus guidelines and final pathologic outcome.
The study is a retrospective review of all patients who underwent surgical resection for intraductal papillary mucinous neoplasm (IPMN) from 2002 to 2013 at our institution. Patients with a preoperative diagnosis of isolated SB-IPMN and FNA results for non-malignant cytology were selected among this surgical cohort for further analysis of preoperative clinical characteristics and outcomes.
A total of 137 patients undergoing resection for IPMN were identified. Of these, 81 patients (59 %) had a component of M-IPMN or invasive disease on FNA, leaving 66 (46 %) patients with SB-IPMN and non-malignant cytology. Invasive adenocarcinoma was found in 8/66 (12 %) patients and high-grade dysplasia (HGD) in 4/66 (8 %) patients. The mean [SD] diameter of benign SB-IPMN was 2.0 cm [1.1] (range 0.3–5.7) vs. that of HGD/invasive disease which was 3.1 cm [1.3] (range 1.5–6.0; P = 0.014). Of the 12 patients found to have HGD or invasive disease, symptoms, mural nodules, and septations were found in 7 (58 %), 5 (42 %), and 6 (50 %), respectively. Tumor staging were as follows: IA (2), IB (2), 2A (4), and 2B (1).
With proper selection criteria, SB-IPMN is associated with a low rate of invasive pancreatic ductal adenocarcinoma at the time of resection. Nevertheless, given the demonstrated incidence of malignancy, appropriate operative candidates should undergo resection.
KeywordsPancreas Pancreatectomy Pancreas surgery Intraductal papillary mucinous neoplasm Side-branch IPMN
Financial and Material Support
No external financial or material support was provided for this study.
Conflict of Interest
The authors declare no competing interest.
Dr. Dortch had full access to all the data in the study and takes responsibility for the integrity of the data, accuracy of the data analysis, and drafting of the manuscript. Dortch, Stauffer, and Asbun are responsible for the concept and design of the study and the critical revision of the manuscript for important intellectual content. Dortch, Stauffer, Asbun, Bhupendra Rawal, and M.S. are responsible for the acquisition, analysis, or interpretation of data.
- 5.Wong J, Weber J, Centeno BA, et al. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound. J Gastrointest Surg. 2013;17(1):78–84; discussion p 84–5.Google Scholar
- 9.Fritz S, Klauss M, Bergmann F, et al., et al. Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg. 2012;256(2):313–320.Google Scholar
- 10.Sahora K, Mino-Kenudson M, Brugge W, et al. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013;258(3):466–475.CrossRefPubMedGoogle Scholar
- 11.Goh BK, Tan DM, Thng CH, et al. Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically treated patients. Ann Surg Oncol. 2014;21(6):1919–1926.CrossRefPubMedGoogle Scholar
- 19.Goh BK. Sendai consensus guidelines for branch-duct IPMN: guidelines are just guidelines. Ann Surg. 2014 Jan 16. [Epub ahead of print]. doi: 10.1097/SLA.0000000000000546.
- 20.Correa-Gallego C, Brennan MF, Fong Y, et al. Liberal resection for (presumed) Sendai negative branch-duct intraductal papillary mucinous neoplasms—also not harmless. Ann Surg. 2014;259(3):e45.Google Scholar